CARLOS SANDOVAL: Open Payments
NPI 1780625822 · KEY LARGO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$898 in 39 payments from 7 companies in 2025. Trend: 2023 $1,021 · 2024 $1,185 · 2025 $898
Food & beverage: $898
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $308 |
| Teva Pharmaceuticals USA, Inc. | 5 | $207 |
| Lundbeck LLC | 5 | $123 |
| Alkermes, Inc. | 5 | $106 |
| E.R. Squibb & Sons, L.L.C. | 4 | $104 |
| Axsome Therapeutics, Inc. | 1 | $30 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $20 |
Products named: VRAYLAR, UZEDY, REXULTI, ARISTADA, COBENFY, AUSTEDO XR, Auvelity, CAPLYTA.
Industry payments across FL — which companies pay providers there.
